Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Double-Masked Placebo-Controlled Dose Range Finding Study of Danicopan in Geographic Atrophy
2021-001198-22Phase 2Active
- Sponsor
- Alexion Pharmaceuticals
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in age-related macular degeneration (AMD) and geographic atrophy (GA) comparing Danicopan with Placebo (2 arms). Started Oct 2021; status: active.
02
Drugs
danicopan
03
Conditions
age-related macular degeneration (AMD)geographic atrophy (GA)
Beyond the preview
Go deeper on 2021-001198-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-001198-22.